business / news / / Barchart
LLY stock has surged 25.5% over the past 52 weeks, outperforming the S&P 500 Index’s ($SPX) 24.1.
Eli Lilly's Q1 2026 EPS is projected to rise 126.1% year-over-year to $7.55.
KEY POINTS
- Analysts expect Eli Lilly's fiscal 2026 EPS to increase 43.5% to $34.73 from 2025.
- Eli Lilly's adjusted operating margin improved by 21.2% over the past two years.
- The average analyst price target for Eli Lilly is $1,239.50, implying a 30.6% upside.
COMPANIES
Summarized by Newsio from Barchart. How we summarize →